| Pharmaceutical active ingredients: |
| HydrochlorothiazideRamipril |
| Available forms, composition and doses of Amprilan HL: |
| Tablets; Oral; Hydrochlorothiazide 12.5 mg; Ramipril 2.5 mg |
| Amprilan HL medical category: |
| Human:Angiotensin-Converting Enzyme inhibitorsThiazide diuretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03AX01 - Hydrochlorothiazide, combinationsC09BA05 - Ramipril and diuretics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| KRKA |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Quinazide | Hydrochlorothiazide; Quinapril Hydrochloride | Malesci Istituto Farmacobiologico |
| Quiril Comp. | Hydrochlorothiazide; Quinapril Hydrochloride | Sandoz |
| Altace HCT | Hydrochlorothiazide; Ramipril | Sanofi-Aventis |
| Altace Plus | Hydrochlorothiazide; Ramipril | Sanofi-Aventis |
| Amprilan HD | Hydrochlorothiazide; Ramipril | KRKA |
| Amprilan ND | Hydrochlorothiazide; Ramipril | KRKA |
| Amprilan NL | Hydrochlorothiazide; Ramipril | KRKA |
| Cardace Comp | Hydrochlorothiazide; Ramipril | Sanofi-Aventis |
| Cardace-H | Hydrochlorothiazide; Ramipril | Sanofi-Aventis |
| Conram H | Hydrochlorothiazide; Ramipril | Concertina Pharma |